Clinical Trial Update: Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous human albumin to improve outcomes after pancreaticoduodenectomy, including pancreatic fistula and related complications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anastomotic Leak
• Delayed Gastric Emptying
• Pancreatic Cancer
• Pancreatic Fistula
• Pancreaticoduodenectomy

Drugs mentioned

• Albumin (intravenous) (Albumin)

Snippet

Sponsor: Universiti Kebangsaan Malaysia Medical Centre | Conditions: Pancreaticoduodenectomy, Pancreatic Fistula | Phase 2 | Status: UNKNOWN